Related Experiment Videos
Safe and efficient ecotropic and amphotropic packaging lines for use in gene transfer experiments
D G Markowitz1, S P Goff, A Bank
1Department of Genetics and Development, Columbia University, College of Physicians and Surgeons, New York, New York 10032.
Transactions of the Association of American Physicians
|January 1, 1988
Summary
Researchers developed safe and efficient retrovirus packaging cell lines for gene therapy. These cell lines, GP + E-86 and GP + envAm12, produce high-titer, helper-free retroviruses, crucial for advancing gene therapy applications in mice and humans.
Area of Science:
- Molecular Biology
- Virology
- Biotechnology
Background:
- High-titer, helper-free retrovirus production is essential for gene therapy.
- Existing retrovirus packaging systems may have limitations in safety or efficiency.
Purpose of the Study:
- To construct and characterize novel retrovirus packaging cell lines for gene therapy.
- To ensure the safety and efficiency of these packaging cell lines in producing retroviruses.
Main Methods:
- Construction of ecotropic (GP + E-86) and amphotropic (GP + envAm12) packaging cell lines.
- Utilizing two plasmids: one for gag and pol genes, another for the env gene, with deletions in psi packaging sequence and 3' LTR.
- Introduction of fragmented helper virus genomes into 3T3 cells.
Main Results:
- Achieved high titers of delta neo or N2 retrovirus, comparable to single-plasmid systems.
- No evidence of wild-type retrovirus generation was observed with GP + E-86 and GP + envAm12 lines.
- Demonstrated safety and efficiency for both murine and human gene therapy applications.
Conclusions:
- The developed packaging cell lines (GP + E-86 and GP + envAm12) are safe and efficient for producing high-titer, helper-free retroviruses.
- These cell lines are suitable for gene therapy experiments in murine and human contexts.
- The fragmented genome approach enhances safety by preventing wild-type retrovirus generation.